La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Shinva Medical InstrumentLtd Crescita futura

Future criteri di controllo 1/6

Shinva Medical InstrumentLtd prevede che gli utili e i ricavi cresceranno rispettivamente di 19.5% e 9.9% all'anno. Si prevede che l'EPS crescerà di 19.6% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 11.3% in 3 anni.

Informazioni chiave

20.0%

Tasso di crescita degli utili

20.5%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili	23.7%
Tasso di crescita dei ricavi	9.0%
Rendimento futuro del capitale proprio	11.0%
Copertura analitica	Low
Ultimo aggiornamento	02 Sep 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Returns At Shinva Medical InstrumentLtd (SHSE:600587) Are On The Way Up

Sep 16

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Aug 08

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Jul 18

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Jun 07

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Apr 22

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Mar 28

Previsioni di crescita degli utili e dei ricavi

SHSE:600587 - Stime future degli analisti e dati finanziari passati (CNY Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	12,729	1,149	N/A	1,319	2
12/31/2025	11,777	963	N/A	1,150	2
12/31/2024	10,837	818	N/A	-208	2
6/30/2024	10,125	680	425	865	N/A
3/31/2024	10,102	669	281	800	N/A
12/31/2023	10,012	654	494	1,030	N/A
9/30/2023	9,948	661	179	730	N/A
6/30/2023	9,919	639	321	757	N/A
3/31/2023	9,608	569	434	757	N/A
12/31/2022	9,282	500	140	388	N/A
9/30/2022	8,778	539	-205	63	N/A
6/30/2022	8,457	550	-37	216	N/A
3/31/2022	9,078	538	465	720	N/A
12/31/2021	9,482	556	1,128	1,403	N/A
9/30/2021	9,974	459	1,571	1,750	N/A
6/30/2021	10,591	435	1,639	1,866	N/A
3/31/2021	9,938	347	1,221	1,429	N/A
12/31/2020	9,151	234	907	1,098	N/A
9/30/2020	8,983	272	722	823	N/A
6/30/2020	8,616	297	602	705	N/A
3/31/2020	8,470	333	360	527	N/A
12/31/2019	8,767	861	415	631	N/A
9/30/2019	9,347	671	258	922	N/A
6/30/2019	9,814	659	328	940	N/A
3/31/2019	10,135	556	418	1,111	N/A
12/31/2018	10,284	23	-73	653	N/A
9/30/2018	10,144	207	346	860	N/A
6/30/2018	10,116	38	144	741	N/A
3/31/2018	10,051	50	N/A	664	N/A
12/31/2017	9,983	66	N/A	959	N/A
9/30/2017	9,551	-100	N/A	554	N/A
6/30/2017	9,091	25	N/A	523	N/A
3/31/2017	8,696	36	N/A	523	N/A
12/31/2016	8,364	35	N/A	189	N/A
9/30/2016	8,139	223	N/A	210	N/A
6/30/2016	7,895	236	N/A	235	N/A
3/31/2016	7,686	244	N/A	-125	N/A
12/31/2015	7,554	281	N/A	110	N/A
9/30/2015	7,256	291	N/A	-110	N/A
6/30/2015	7,000	308	N/A	-209	N/A
3/31/2015	6,749	320	N/A	-76	N/A
12/31/2014	6,283	326	N/A	52	N/A
9/30/2014	5,613	303	N/A	-19	N/A
6/30/2014	4,999	280	N/A	-29	N/A
3/31/2014	4,476	265	N/A	5	N/A
12/31/2013	4,194	232	N/A	22	N/A
9/30/2013	3,856	216	N/A	12	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di 600587 ( 19.5% all'anno) è superiore al tasso di risparmio ( 2.9% ).

Guadagni vs Mercato: Si prevede che gli utili di 600587 ( 19.2% all'anno) cresceranno più lentamente rispetto al mercato CN ( 22.5% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di 600587 cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di 600587 ( 9.9% all'anno) crescerà più lentamente rispetto al mercato CN ( 13.4% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 600587 ( 9.9% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di 600587 sarà basso tra 3 anni ( 11.3 %).

Shinva Medical InstrumentLtd Crescita futura

Future criteri di controllo 1/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Price target increased to CN¥41.65

Recent updates

Returns At Shinva Medical InstrumentLtd (SHSE:600587) Are On The Way Up

Second quarter 2024 earnings released: EPS: CN¥0.74 (vs CN¥0.43 in 2Q 2023)

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Now 19% overvalued

Shinva Medical Instrument Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Now 22% overvalued

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Investor sentiment deteriorates as stock falls 17%

Dividend increased to CN¥0.50

First quarter 2024 earnings released: EPS: CN¥0.45 (vs CN¥0.46 in 1Q 2023)

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Full year 2023 earnings: EPS and revenues miss analyst expectations

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Investor sentiment deteriorates as stock falls 19%

Shinva Medical Instrument Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.24 in 3Q 2022)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.57 (vs CN¥0.48 in 2Q 2022)

New minor risk - Dividend sustainability

Full year 2022 earnings released: EPS: CN¥1.23 (vs CN¥1.37 in FY 2021)

Investor sentiment improves as stock rises 17%

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.48 (vs CN¥0.45 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to CN¥41.65

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.25 in 2Q 2020)

Investor sentiment improved over the past week

Zou Huiling acquired 16.67% stake in Beijing Huaco Healthcare Technologies Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 25 million.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.08 in 1Q 2020)

New 90-day low: CN¥12.23

New 90-day low: CN¥13.25

New 90-day low: CN¥14.41

New 90-day low: CN¥14.78

New 90-day low: CN¥15.88

Third quarter earnings released

Shinva Medical Instrument Co., Ltd. to Report Q3, 2020 Results on Oct 31, 2020

First half earnings released

Nanyang Great Health Medical Care Industry Development Co., Ltd acquired 80% stake in Nanyang Orthopedics High-tech Zone Hospital Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 53.8 million.

New 90-day high - CN¥18.41

Shinva Medical Instrument Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita